Publication | Closed Access
Tiludronate as a new therapeutic agent in the treatment of navicular disease: a double‐blind placebo‐controlled clinical trial
113
Citations
13
References
2003
Year
Our results support the clinical relevance of bone remodelling changes in the outcome of navicular disease.
| Year | Citations | |
|---|---|---|
Page 1
Page 1